How Nike Stock Is Hurdling the Coronavirus
Nike released mixed fiscal third-quarter financial results late on Tuesday, but shares were sharply higher early Wednesday.
Nike released mixed fiscal third-quarter financial results late on Tuesday, but shares were sharply higher early Wednesday.
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The March 13 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
No industry has been safe from the market carnage due to the coronavirus pandemic. It’s uncertain if a bottom is in sight yet, but investors already are beginning to ask themselves which industries will…
Tesla was an absolute market darling going into this coronavirus scare. Since then, it has sold off with the rest of the market, and now it has been downgraded.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
While the third-quarter results may not entirely reflect the effect of the coronavirus outbreak, they will provide some picture of what’s going on with Nike.
This dramatic impairment of economic activity in the United States and around the world will make for some very ugly economic numbers.
While most businesses are laying off or furloughing employees, Dollar General is going in the opposite direction.
Aytu BioScience was largely unknown until it announced that it had a test for COVID-19. Since then, it has seen a meteoric rise in its common stock price. Does the future look bright?
24/7 Wall St. has put together a preview of Carnival, Micron, Nike and a few of the other most anticipated quarterly reports due this week.
U.S. consumer confidence has again sunk to its lowest level ever, especially among high-income consumers who are responsible for most discretionary spending.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
GenMark Diagnostics stock shot up on Friday after the company announced that the FDA has issued an Emergency Use Authorization for the company’s ePlex SARS-CoV-2 test.
Here are the social media companies that are on the frontline of the war on coronavirus misinformation, as well as look at how their shares are responding to the outbreak.
Why are these ride-sharing rivals Uber and Lyft making a run in the midst of this coronavirus pandemic? At one of them, things look to be turning around.
Blue Apron stock again leaped forward Thursday as more investors flock to the online food delivery service. Has anything really changed at this company?
The Dow Jones industrials are down over 30% from its all-time high in mid-February, but Walmart is actually up about 7% since then. Is Walmart recession-proof?
Lyft and its main rival have not avoided the stock market turmoil, but they could offer a solid investment vehicle out of this crisis.
Amarin has been right in the middle of this recent market sell-off, and while shares have been halved, the stock could be poised for a strong recovery. All the pieces seem to be there.